Mountain West AIDS Education and Training Center (MWAETC)

OD presentation return node

« Return to MWAETC On-Demand Presentations

Long-Acting Cabotegravir / Rilpivirine for Individuals With Detectable Viral Loads

Presentation Date: 2023-01-12

Presentation Length: 22:04

Presenters: Monica Gandhi, MD, MPH

Presentation Categories: HIV ECHO

Presentation Tags: Long- Acting ART/Injectables, Anti-Retroviral Therapy (ART), Salvage Treatment/Resistance

Presentation Slides:

Download (2.322 MB)

Presentation Downloads:

Related Documents:

Related Links:

Related Presentations:

Presentation Details:
Dr. Monica Gandhi shares experience and data from UCSF with prescribing injectable, long-acting cabotegravir/rilpivirine (Cabenuva) for persons with HIV with detectable viral loads and discusses potential benefits and risks of this off-label strategy.

Presentation Transcript:

MOUNTAIN WEST AIDS EDUCATION AND TRAINING CENTER

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $2,982,063 with 0% financed with non-governmental sources. The content in presentations are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.